GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

•For patients with type 2 diabetes and heart failure with preserved ejection fraction, GLP-1 receptor agonist (GLP-1RA) medications may improve various heart and kidney-related outcomes even for those without obesity.•GLP-1RAs could provide incremental benefits to patients already taking other diabe...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cardiac failure 2024-12
Hauptverfasser:	Khadke, Sumanth, Kumar, Ashish, Bhatti, Ammar, Dani, Sourbha S., Al-Kindi, Sadeer, Nasir, Khurram, Virani, Salim S., Upadhyay, Jagriti, Garcia-Banigan, Dinamarie C., Abraham, Sonu, Husami, Raya, Kong, Yixin, Labib, Sherif, Venesy, David, Shah, Sachin, Lenihan, Daniel, Vaduganathan, Muthiah, Deswal, Anita, Fonarow, Gregg C., Butler, Javed, Nohria, Anju, Kosiborod, Mikhail N., Ganatra, Sarju
Format:	Artikel
Sprache:	eng
Schlagworte:	GLP-1R agonists Heart failure with preserved ejection fraction SGLT 2 inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!